No Longer Accepting Claims
Roundup Lawsuit Facts
TorHoerman Law is no longer accepting claims for the Roundup Lawsuit.
Intake Closed
Glyphosate, the active ingredient in the widely used herbicide Roundup, has been at the center of a heated debate regarding its potential link to cancer, specifically non-Hodgkin’s lymphoma (NHL).
In 2015, the International Agency for Research on Cancer (IARC), a branch of the World Health Organization, classified glyphosate as a “probable human carcinogen,” raising significant concerns about its safety.
This classification was based on evidence suggesting a link between glyphosate exposure and increased risk of developing Non-Hodgkin’s Lymphoma, a type of cancer affecting the lymphatic system.
Following the IARC’s classification, public and scientific scrutiny of Roundup’s safety intensified, leading to widespread debates and research into the potential health risks of glyphosate.
As a result, thousands of Roundup cancer lawsuits have been filed against Monsanto by individuals alleging that their exposure to Roundup contributed to their development of Non-Hodgkin’s Lymphoma.
These lawsuits argue that Monsanto failed to warn consumers about the risks associated with glyphosate use.
In response to the mounting legal challenges, Monsanto, which was acquired by Bayer AG in 2018, faced significant financial and reputational repercussions.
In 2020, Bayer announced a massive $10 billion settlement to resolve most of the Roundup lawsuits centralized in the United States District Court for the Northern District of California.
If you or a loved one have been exposed to Roundup and diagnosed with Non Hodgkin Lymphoma, you may be eligible to file a Roundup lawsuit.
Contact the experienced Roundup lawyers at TorHoerman Law for a free case review.
You can also use the chatbot on this page to find out if you qualify to file a Roundup lawsuit instantly.
About Roundup Weed Killer and It’s Popularity.
Roundup, developed and produced by Monsanto (which has since been acquired by Bayer), made its debut in the market in the 1970s.
Roundup’s active ingredient, glyphosate, operates by inhibiting a specific enzyme pathway, the shikimate pathway, crucial for plant growth.
This process effectively prevents plants from synthesizing certain essential amino acids, leading to their rapid decline and death.
The innovative mechanism of action of glyphosate set Roundup apart from other herbicides available at the time.
Roundup’s ability to control a broad spectrum of weeds and grasses with minimal direct impact on the crops, animals, and humans in close proximity contributed significantly to its widespread adoption.
Roundup was popularized for its convenience and efficiency, becoming a go-to solution for agriculturalists, horticulturists, and homeowners alike.
Its usage spanned across various settings, from large-scale farms to backyard gardens.
Another factor contributing to Roundup’s popularity was the development of genetically modified (GM) crops that were resistant to glyphosate.
Introduced in the mid-1990s, these ‘Roundup Ready’ crops, such as soybeans, corn, and cotton, allowed farmers to apply the herbicide directly to their fields, killing weeds without harming the crops.
Despite its widespread use and popularity, the later years brought challenges and controversies, particularly concerning the safety of glyphosate and its potential health risks to humans and the environment.
Epidemiological Studies: Roundup Linked to Cancer
The controversy surrounding Roundup escalated when claims emerged that exposure to glyphosate was linked to an increased risk of developing non-Hodgkin’s lymphoma and potentially other forms of cancer.
Non-Hodgkin’s lymphoma is a type of cancer that affects the lymphatic system, the body’s immune system.
The symptoms of NHL can vary depending on the subtype and the organs affected.
Common symptoms include swollen lymph nodes, night sweats, fever, fatigue, unexplained weight loss, and abdominal pain or swelling.
Since these symptoms can be associated with various medical conditions, diagnosing NHL often requires a combination of physical examinations, imaging tests, and biopsies.
Numerous epidemiological studies have been conducted to investigate the alleged association between Roundup exposure and NHL.
One of the pivotal studies that fueled concerns was a 2015 report by the International Agency for Research on Cancer (IARC), a branch of the World Health Organization (WHO).
The IARC classified glyphosate as a Group 2A substance, indicating that it is “probably carcinogenic to humans.”
This classification intensified the debate and triggered legal action against Monsanto.
Lawsuits Filed: Plaintiffs Claim Roundup Caused Cancer
Several thousand Roundup lawsuits have been filed as individuals who developed non-Hodgkin’s lymphoma after Roundup exposure.
In a landmark case in 2018, a California jury awarded $289 million to a groundskeeper who claimed that Roundup exposure contributed to his terminal cancer.
The jury found Monsanto liable for failing to warn users about the potential cancer risks associated with glyphosate.
In December 2023, Bayer faced another legal setback as a Philadelphia jury ordered the company to pay nearly $3.5 million in connection with the weed killer Roundup allegedly causing a woman’s cancer.
This marks Bayer’s fifth consecutive Roundup cancer trial loss.
However, the verdict is considerably smaller than previous ones, totaling over $2 billion.
The recent ruling includes $462,500 in compensatory damages and $3 million in punitive damages, with a split jury decision of 10-2.
While some argue that the legal victories validate the alleged link between Roundup and cancer, others question the scientific rigor of the courtroom decisions, emphasizing that legal proceedings are not equivalent to scientific evidence.
Despite ongoing legal challenges, Bayer has expressed selectivity in settling Roundup cases, emphasizing reserves to handle litigation costs.
In 2020, the company settled most pending Roundup cases for up to $10 billion but fell short of a comprehensive resolution for future claims.
Regulatory Responses and Glyphosate Bans
The controversy has prompted regulatory bodies worldwide to reevaluate their stance on glyphosate.
In 2022, the EPA announced the removal of all outstanding sections of the interim registration review decision for glyphosate.
Glyphosate-containing pesticide products will persist on the market and can be utilized in accordance with the product label, unaffected by this measure.
Conversely, certain countries and regions have taken a more precautionary approach.
For example, Austria became the first European Union member to ban the use of glyphosate in 2020, citing environmental and health concerns.
Similarly, several municipalities and states in the United States have implemented restrictions on glyphosate use.
